Breaking News Instant updates and real-time market news.

EVRI

Everi Holdings

$7.42

-0.01 (-0.13%)

17:26
08/08/17
08/08
17:26
08/08/17
17:26

Everi Holdings raises FY17 adjusted EBITDA to $209M-$212M

The updated outlook reflects the following key assumptions: the Company continues to expect that full year unit sales for the Games segment will increase 12%-15% from the 2,954 units sold in 2016. Unit sales for the second half of 2017 are expected to be less than the 1,703 units sold in the second half of 2016 as unit sales in the second half of 2016 benefited from 200 units sold to the Alberta Gaming and Liquor Commission in the Q3 of 2016, as well as from a solid level of unit sales to several new casinos that opened in the second half of 2016 with no comparable level of new casino openings expected in the second half of 2017. The installed base for the Games segment at December 31 is expected to be higher than the reported installed base at December 31, 2016. The Company expects to benefit from the continued rollout of its Jackpot Lockdown Class II wide-area progressive product. This growth in the installed base over the balance of 2017 includes the expectation that the Company's remaining third-party Class III units will not change materially throughout the rest of the year and that an estimated 200 Class II units will be removed from certain tribal customer facilities due to changes in tribal gaming compacts with the State of California over the remainder of the year. Based on the expected growth in the Company's installed base in the Q3 and Q4, the expected growth in placements of higher performing WAP and other premium units, and the lessening impact from removals of higher performing third-party Class III units than in prior periods, the Company expects an improvement in the DWPU performance in the second half of 2017 and believes revenue from the installed base portion of gaming operations in the second half of 2017 will exceed the installed base revenue generated in the first half of 2017. Quarterly revenue and Adjusted EBITDA for the Company's Payments segment is expected to grow year over year. The Company expects growth in Payments segment revenues in the mid-single digits and growth in Adjusted EBITDA in the low single digits compared to the second half of 2016. These growth percentages also reflect several new casino wins in the second half of 2016 that have their first anniversary of service in the second half of 2017.

  • 08

    Aug

EVRI Everi Holdings
$7.42

-0.01 (-0.13%)

03/15/17
TLSY
03/15/17
UPGRADE
Target $6
TLSY
Outperform
Everi Holdings upgraded to Outperform from Market Perform at Telsey Advisory
Telsey Advisory analyst David Katz upgraded Everi Holdings to Outperform and raised his price target for the shares to $6 from $2.50.
03/15/17
CHLM
03/15/17
UPGRADE
Target $5
CHLM
Buy
Everi Holdings upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst George Sutton upgraded Everi Holdings to Buy citing evidence of a turnaround and growing free cash flow following the company's Q4 results. The analyst raised his price target for the shares to $5 from $4. Telsey Advisory this morning upgraded the shares to Outperform.
06/12/17
STFL
06/12/17
NO CHANGE
STFL
Everi Holdings momentum continuing, says Stifel
After meeting with Everi's management, Stifel analyst John Davis says that "the company has continued to build on recent momentum, especially in the Games business." He thinks that the stock has one of the best risk/reward ratios in his coverage and raised the price target on the shares to $9 from $7.50 while keeping a Buy rating on the stock.

TODAY'S FREE FLY STORIES

IMPV

Imperva

$45.65

-0.6 (-1.30%)

, FIVN

Five9

$43.21

-1.32 (-2.96%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Conference/Events
Microsoft to hold a conferenc e »

Microsoft Ignite will be…

IMPV

Imperva

$45.65

-0.6 (-1.30%)

FIVN

Five9

$43.21

-1.32 (-2.96%)

CDAY

Ceridian

$42.07

-0.855 (-1.99%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 28

    Nov

  • 03

    Mar

MNKD

MannKind

$1.71

0.02 (1.18%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Hot Stocks
MannKind completes cohort 1, opens enrollment of cohort 2 for Afrezza study »

MannKind announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

CZR

Caesars

$10.78

-0.175 (-1.60%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Hot Stocks
Caesars names Monica Digilio as Chief Human Resources Officer »

Caesars Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$147.81

-5.105 (-3.34%)

09:06
09/24/18
09/24
09:06
09/24/18
09:06
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$6.46

-0.05 (-0.77%)

, CMCSA

Comcast

$37.91

0.1 (0.26%)

09:05
09/24/18
09/24
09:05
09/24/18
09:05
Periodicals
Tile names GoPro vet CJ Prober CEO, adds Comcast as investor, TechCrunch says »

Tile is appointing CJ…

GPRO

GoPro

$6.46

-0.05 (-0.77%)

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNBX

Cannabics Pharmaceuticals

$0.00

(0.00%)

09:04
09/24/18
09/24
09:04
09/24/18
09:04
Syndicate
Cannabics Pharmaceuticals raises $7.5M in a registered direct offering »

Cannabics Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$107.62

-0.32 (-0.30%)

09:03
09/24/18
09/24
09:03
09/24/18
09:03
Recommendations
Quest Diagnostics analyst commentary  »

Quest Diagnostics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALPMY

Astellas Pharma

$0.00

(0.00%)

, PFE

Pfizer

$44.06

0.3 (0.69%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Hot Stocks
Astellas Pharma receives positive CHMP opinion for Xtandi »

Astellas Pharma announced…

ALPMY

Astellas Pharma

$0.00

(0.00%)

PFE

Pfizer

$44.06

0.3 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

ALT

Altimmune

$26.03

0.53 (2.08%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Syndicate
Altimmune raises $4.9M in a registered direct offering »

Altimmune announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALT

Altimmune

$26.03

0.53 (2.08%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Syndicate
Altimmune announces $4.9M registered direct offering of common stock »

Altimmune announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$69.05

0.25 (0.36%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Recommendations
Abbott analyst commentary  »

Abbott Mitraclip data a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
Breaking Hot Stocks news story on Sirius XM »

Sirius XM doesn't…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

PDLI

PDL BioPharma

$2.42

-0.02 (-0.82%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
PDL BioPharma announces new $100M share repurchase program »

PDL BioPharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBEV

New Age Beverages

$6.15

-1.7 (-21.66%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Syndicate
New Age Beverages to offer up to $50M in shares via 'At the Market' offering »

New Age Beverages…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
Sirius XM says company, Pandora to pay royalties approaching $2B in 2019 »

Sirius XM (SIRI) says…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

RDC

Rowan Companies

$18.02

0.54 (3.09%)

08:59
09/24/18
09/24
08:59
09/24/18
08:59
Upgrade
Rowan Companies rating change  »

Rowan Companies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SEAS

SeaWorld

$30.10

-0.5 (-1.63%)

08:58
09/24/18
09/24
08:58
09/24/18
08:58
Recommendations
SeaWorld analyst commentary  »

SeaWorld price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTRX

Lantronix

$4.14

-0.12 (-2.82%)

08:58
09/24/18
09/24
08:58
09/24/18
08:58
Recommendations
Lantronix analyst commentary  »

Lantronix shares can see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AAPL

Apple

$217.65

-2.35 (-1.07%)

08:57
09/24/18
09/24
08:57
09/24/18
08:57
Recommendations
Apple analyst commentary  »

Rosenblatt says Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TEUM

Pareteum

$2.80

-0.03 (-1.06%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Initiation
Pareteum initiated  »

Pareteum initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTV

Fortive

$86.97

-0.45 (-0.51%)

, AAPL

Apple

$217.65

-2.35 (-1.07%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Options
Notable open interest changes for September 24th »

Friday's total…

FTV

Fortive

$86.97

-0.45 (-0.51%)

AAPL

Apple

$217.65

-2.35 (-1.07%)

AMD

AMD

$31.01

-0.17 (-0.55%)

MU

Micron

$44.70

-1.36 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

, ANDV

Andeavor

$154.80

2.19 (1.44%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Conference/Events
Andeavor to host special shareholder meeting »

Special Shareholder…

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

ANDV

Andeavor

$154.80

2.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

08:54
09/24/18
09/24
08:54
09/24/18
08:54
Hot Stocks
Breaking Hot Stocks news story on Sirius XM, Pandora, Spotify »

Sirius XM sees taking…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

SPOT

Spotify

$175.06

2.38 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

UNFI

United Natural Foods

$31.02

-2.81 (-8.31%)

, SVU

Supervalu

$32.24

0.02 (0.06%)

08:52
09/24/18
09/24
08:52
09/24/18
08:52
Recommendations
United Natural Foods, Supervalu analyst commentary  »

United Natural Foods…

UNFI

United Natural Foods

$31.02

-2.81 (-8.31%)

SVU

Supervalu

$32.24

0.02 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

MU

Micron

$44.70

-1.36 (-2.95%)

, INTC

Intel

$46.64

-0.56 (-1.19%)

08:52
09/24/18
09/24
08:52
09/24/18
08:52
Recommendations
Micron, Intel analyst commentary  »

Micron price target…

MU

Micron

$44.70

-1.36 (-2.95%)

INTC

Intel

$46.64

-0.56 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.